Differential effects of trivalent and pentavalent arsenicals on cell proliferation and cytokine secretion in normal human epidermal keratinocytes

Toxicology and Applied Pharmacology

Volumn 172, Issue 3, 2001, Pages 225-232

  Vega, Libia ^a   Styblo, Miroslav ^b   Patterson, Rachel ^a   Cullen, William ^c   Wang, Changqing ^c   Germolec, Dori ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Arsenate; Arsenite; Cell proliferation; Cytokine secretion; DMA; Keratinocytes; Metabolism; MMA; Viability

Indexed keywords

ARSENIC ACID; ARSENIC DERIVATIVE; ARSENIC TRIOXIDE; CYTOKINE; GLUTATHIONE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL PROLIFERATION; CELL VIABILITY; EPIDERMIS CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; KERATINOCYTE; SKIN TOXICITY;

EID: 0035341194     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.2001.9152     Document Type: Article

References (66)

1. Cytokine modulation of keratinocyte cytokines
2. Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity
3. How is inorganic arsenic detoxified?
4. Occurence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic
5. Arsenic induces oxidant stress and NF-κB activation in cultured aortic endothelial cells
6. Stimulation of reactive oxygen, but not reactive nitrogen species, in vascular endothelial cells exposed to low levels of arsenite
7. Keratinocytes as initiators of inflammation
8. Cellular uptake and metabolic reduction of pentavalent to trivalent arsenic as determinants of cytotoxicity and morphological transformation
9. Expression of p53 in arsenic-related and sporadic basal cell carcinoma
10. Dimethylarsinic acid treatment alters six different rat biochemical parameters: Relevance to arsenic carcinogenesis
11. Consistency of biomarkers of exposure to inorganic arsenic: Review of recent data
12. Dermatotoxic chemical stimulation of c-jun and c-fos transcription and AP-1 DNA binding in human keratinocytes
13. Expression of bcl-2, p53 and Ki-67 in arsenical skin cancers
14. Ground-water arsenic contamination and suffering of people in Bangladesh
15. Sodium arsenate induces overproduction of interleukin-1α in murine keratinocytes: Role of mitochondria
16. The reaction of methylarsenicals with thiols: Some biological implications
17. Reduction and binding of arsenate and dimethylarsenate by glutathione: A multinuclear magnetic resonance study
18. The NF-κB/Rel family of transcription factors in oncogenic transformation and apoptosis
19. Heat shock proteins in cultured human keratinocytes and fibroblasts
20. Arsenic uptake, cytotoxicity and detoxification studied in mammalian cells in culture
21. Arsenic induces overexpression of growth factors in human keratinocytes
22. Arsenic can mediate skin neoplasia by chronic stimulation of keratinocyte-derived growth factors
23. Arsenic enhancement of skin neoplasia by chronic stimulation of growth factors
24. The enigma of arsenic carcinogenesis: Role of metabolism
25. Detection of transforming growth factor alpha in normal malignant and hyperproliferative human keratinocytes
26. Characterization of label-retaining cells in the epidermis of a human skin equivalent
27. Arsenic disrupts cellular levels of p53 and mdm2: A potential mechanism of carcinogenesis
28. Flow cytometric analysis of pig epidermal keratinocytes: Effects of ultraviolet B irradiation (UVB) and topical PUVA treatment
29. Enzymatic methylation of arsenic compounds. V. Arsenite methyltransferase activity in tissues of mice
30. DMPS modulation of arsenic species, including monomethylarsonous acid (MMAIII), in human urine
31. Mutagenicity of arsenic in mammalian cells: Role of reactive oxygen species
32. Cellular uptake of trivalent arsenite and pentavalent arsenate in KB cells cultured in phosphate-free medium
33. Arsenate suppression of human keratinocyte programming
34. Differential effects of arsenic(III) and chromium(VI) on nuclear transcription factor binding
35. Modulation of cellular antioxidant defense activities by sodium arsenite in human fibroblasts
36. Arsenic uptake and metabolism by liver cells is dependent on arsenic oxidation state
37. Promotion of NCI-Black-Reiter male rat bladder carcinogenesis by dimethylarsinic acid an organic arsenic compound
38. Methylasenicals and arsinothiols are potent inhibitors of mouse liver thioredoxin reductase
39. Epidermal cell-derived cytokines
40. Autocrine growth limitation of human papillomavirus type 16-harboring keratinocytes by constitutively released tumor necrosis factor-α
41. Reciprocal cytokine-mediated cellular interactions in mouse epidermis: Promotion of gd T-cell growth by IL-7 and TNFα and inhibition of keratinocyte growth by gIFN
42. Arsenic levels in drinking water and the prevalence of skin lesions in West Bengal, India
43. Relative genotoxic potency of arsenic and its methylated metabolites
44. Induction of transcription factor AP-2 by inflammatory cytokines in human keratinocytes
45. Production of interleukin-1 and interleukin-6 by human keratinocytes and squamous cell carcinoma cell lines
46. Monomethylarsonous acid (MMAIII) is more toxic than arsenite in Chang human hepatocytes
47. Signal transduction pathways regulated by arsenate and arsenite
48. 74As-labeled arsenate and arsenite for use in biological experiments
49. Human cells lack the inducible tolerance to arsenite seen in hamster cells
50. Inorganic and methylated arsenic compounds induce cell death in murine macrophages via different mechanisms
51. Reduction of arsenic(III) and arsenic(V) species with glutathione
52. Arsenic mediates cell proliferation and gene expression in the bladder epithelium: Association with activating protein-1 transactivation
53. Comparative methylation of trivalent and pentavalent arsenicals
54. Liberation and analysis of protein-bound arsenicals
55. Binding of arsenicals to proteins in an in vitro methylation system
56. Comparative inhibition of yeast glutathione reductase by arsenicals and arsenothiols
57. Metabolism of arsenic in primary cultures of human and rat hepatocytes
58. Metabolism and toxicity of arsenicals in cultured cells
59. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells
60. Biotransformation of trivalent and pentavalent inorganic arsenic in mice and rats
61. Species differences in the metabolism of arsenic compounds
62. Cell kinetic characterization of growth arrest in cultured human keratinocytes
63. Granulocyte-macrophage colony-stimulating factor (GM-CSF) is expressed in mouse skin in response to tumor-promoting agents and modulates dermal inflammation and epidermal dark cell numbers
64. Cancer induction by an organic arsenic compound, dimethylarsinic acid (cacodylic acid), in F344/DuCrj rats after pretreatment with five carcinogens
65. Exposure to dimethylarsinic acid, a main metabolite of inorganic arsenic, strongly promotes tumorigenesis initiated by 4-nitroquinoline-1-oxide in the lungs of mice